Original paper
Molecular Characterization of Residual Bladder Cancer after Neoadjuvant Pembrolizumab
Abstract
In patients with muscle-invasive urothelial bladder cancer (MIBC), molecular alterations in immunotherapy-resistant tumors found at radical cystectomy (RC) remain largely unstudied.To investigate the biology of pembrolizumab-resistant tumors in comparison to an RC cohort treated without any systemic therapy and a cohort of neoadjuvant chemotherapy (NAC)-treated tumors.Transcriptome-wide expression profiling was performed on 26 RC samples from...
Paper Details
Title
Molecular Characterization of Residual Bladder Cancer after Neoadjuvant Pembrolizumab
Published Date
Aug 1, 2021
Journal
Volume
80
Issue
2
Pages
149 - 159
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History